메뉴 건너뛰기




Volumn 2010, Issue , 2010, Pages

Preventive but Not curative efficacy of celecoxib on bladder carcinogenesis in a rat model

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2; N BUTYL N (4 HYDROXYBUTYL)NITROSAMINE; ANTINEOPLASTIC AGENT; AUTACOID; CYCLOOXYGENASE 2 INHIBITOR; PYRAZOLE DERIVATIVE; SULFONAMIDE;

EID: 79953288402     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2010/380937     Document Type: Article
Times cited : (14)

References (39)
  • 2
    • 33847638137 scopus 로고    scopus 로고
    • Estimates of the cancer incidence and mortality in Europe in 2006
    • DOI 10.1093/annonc/mdl498
    • Ferlay J., Autier P., Boniol M., Heanue M., Colombet M., Boyle P., Estimates of the cancer incidence and mortality in Europe in 2006 Annals of Oncology 2007 18 3 581 592 (Pubitemid 46359643)
    • (2007) Annals of Oncology , vol.18 , Issue.3 , pp. 581-592
    • Ferlay, J.1    Autier, P.2    Boniol, M.3    Heanue, M.4    Colombet, M.5    Boyle, P.6
  • 5
    • 43849088953 scopus 로고    scopus 로고
    • Bladder cancer: A major public health issue
    • Grasso M., Bladder cancer: a major public health issue European Urology, Supplements 2008 7 7 510 515
    • (2008) European Urology, Supplements , vol.7 , Issue.7 , pp. 510-515
    • Grasso, M.1
  • 6
    • 32944465832 scopus 로고    scopus 로고
    • Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials
    • DOI 10.1016/j.eururo.2005.12.031, PII S0302283805008523
    • Sylvester R. J., Van Der Meijden A. P. M., Oosterlinck W., Witjes J. A., Bouffioux C., Denis L., Newling D. W. W., Kurth K., Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials European Urology 2006 49 3 466 475 (Pubitemid 43259554)
    • (2006) European Urology , vol.49 , Issue.3 , pp. 466-475
    • Sylvester, R.J.1    Van Der Meijden, A.P.M.2    Oosterlinck, W.3    Witjes, J.A.4    Bouffioux, C.5    Denis, L.6    Newling, D.W.W.7    Kurth, K.8
  • 8
    • 0037366062 scopus 로고    scopus 로고
    • Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder
    • DOI 10.1097/01.ju.0000043638.89552.ed
    • Shariat S. F., Kim J. H., Ayala G. E., Kho K., Wheeler T. M., Lerner S. P., Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder Journal of Urology 2003 169 3 938 942 (Pubitemid 36188129)
    • (2003) Journal of Urology , vol.169 , Issue.3 , pp. 938-942
    • Shariat, S.F.1    Kim, J.-H.2    Ayala, G.E.3    Kho, K.4    Wheeler, T.M.5    Lerner, S.P.6
  • 10
    • 36249004425 scopus 로고    scopus 로고
    • The genetics of bladder cancer: A cytogeneticist's perspective
    • DOI 10.1159/000108298
    • Wolff D. J., The genetics of bladder cancer: a cytogeneticist's perspective Cytogenetic and Genome Research 2007 118 24 177 181 (Pubitemid 350125254)
    • (2007) Cytogenetic and Genome Research , vol.118 , Issue.2-4 , pp. 177-181
    • Wolff, D.J.1
  • 11
    • 60349104574 scopus 로고    scopus 로고
    • Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer
    • Ahirwar D., Mandhani A., Mittal R. D., Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer Archives of Medical Research 2009 40 2 97 102
    • (2009) Archives of Medical Research , vol.40 , Issue.2 , pp. 97-102
    • Ahirwar, D.1    Mandhani, A.2    Mittal, R.D.3
  • 12
    • 34547578958 scopus 로고    scopus 로고
    • Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer
    • Harris R. E., Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer Sub-Cellular Biochemistry 2007 42 93 126
    • (2007) Sub-Cellular Biochemistry , vol.42 , pp. 93-126
    • Harris, R.E.1
  • 13
    • 0034062380 scopus 로고    scopus 로고
    • Cyclo-oxygenase isoenzymes: Physiological and pharmacological role
    • DOI 10.1046/j.1365-2044.2000.01271.x
    • Kam P. C. A., See A. U. L., Cyclo-oxygenase isoenzymes: physiological and pharmacological role Anaesthesia 2000 55 5 442 449 (Pubitemid 30301443)
    • (2000) Anaesthesia , vol.55 , Issue.5 , pp. 442-449
    • Kam, P.C.A.1    See, A.U.-L.2
  • 14
    • 67650065464 scopus 로고    scopus 로고
    • Cyclooxygenase-2 expression is associated with vascular endothelial growth factor-C and lymph node metastases in human prostate cancer
    • Di J. M., Zhou J., Zhou X. L., Gao X., Shao C. Q., Pang J., Sun QI. P., Zhang Y., Ruan X. X., Cyclooxygenase-2 expression is associated with vascular endothelial growth factor-C and lymph node metastases in human prostate cancer Archives of Medical Research 2009 40 4 268 275
    • (2009) Archives of Medical Research , vol.40 , Issue.4 , pp. 268-275
    • Di, J.M.1    Zhou, J.2    Zhou, X.L.3    Gao, X.4    Shao, C.Q.5    Pang, J.6    Sun, Q.I.P.7    Zhang, Y.8    Ruan, X.X.9
  • 15
    • 33745932131 scopus 로고    scopus 로고
    • Chemopreventive potential of diallylsulfide, lycopene and theaflavin during chemically induced colon carcinogenesis in rat colon through modulation of cyclooxygenase-2 and inducible nitric oxide synthase pathways
    • DOI 10.1097/00008469-200608000-00005, PII 0000846920060800000005
    • Sengupta A., Ghosh S., Das R. K., Bhattacharjee S., Bhattacharya S., Chemopreventive potential of diallylsulfide, lycopene and theaflavin during chemically induced colon carcinogenesis in rat colon through modulation of cyclooxygenase-2 and inducible nitric oxide synthase pathways European Journal of Cancer Prevention 2006 15 4 301 305 (Pubitemid 44060487)
    • (2006) European Journal of Cancer Prevention , vol.15 , Issue.4 , pp. 301-305
    • Sengupta, A.1    Ghosh, S.2    Das, R.K.3    Bhattacharjee, S.4    Bhattacharya, S.5
  • 16
    • 34147221918 scopus 로고    scopus 로고
    • MR monitoring of cyclooxygenase-2 inhibition of angiogenesis in a human breast cancer model in rats
    • DOI 10.1148/radiol.2431050658
    • Fournier L. S., Novikov V., Lucidi V., Fu Y., Miller T., Floyd E., Shames D. M., Brasch R. C., MR monitoring of cyclooxygenase-2 inhibition of angiogenesis in a human breast cancer model in rats Radiology 2007 243 1 105 111 (Pubitemid 46579700)
    • (2007) Radiology , vol.243 , Issue.1 , pp. 105-111
    • Fournier, L.S.1    Novikov, V.2    Lucidi, V.3    Fu, Y.4    Miller, T.5    Floyd, E.6    Shames, D.M.7    Brasch, R.C.8
  • 17
    • 0342369370 scopus 로고    scopus 로고
    • Nonsteroidal anti-inflammatory drugs (NSAIDs) in the prevention of colorectal cancer
    • Stockbrgger R. W., Nonsteroidal anti-inflammatory drugs (NSAIDs) in the prevention of colorectal cancer European Journal of Cancer Prevention 1999 8 1, supplement S21 S25
    • (1999) European Journal of Cancer Prevention , vol.8 , Issue.1 SUPPL.
    • Stockbrgger, R.W.1
  • 18
    • 0033401645 scopus 로고    scopus 로고
    • Increased expression of cyclooxygenase-2 protein in rat urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl) nitrosamine
    • Kitayama W., Denda A., Okajima E., Tsujiuchi T., Konishi Y., Increased expression of cyclooxygenase-2 protein in rat urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl) nitrosamine Carcinogenesis 1999 20 12 2305 2310 (Pubitemid 30015903)
    • (1999) Carcinogenesis , vol.20 , Issue.12 , pp. 2305-2310
    • Kitayama, W.1    Denda, A.2    Okajima, E.3    Tsujiuchi, T.4    Konishi, Y.5
  • 19
    • 0034099597 scopus 로고    scopus 로고
    • Cyclooxygenase-2 expression is up-regulated in transitional cell carcinoma and its preneoplastic lesions in the human urinary bladder
    • Shirahama T., Cyclooxygenase-2 expression is up-regulated in transitional cell carcinoma and its preneoplastic lesions in the human urinary bladder Clinical Cancer Research 2000 6 6 2424 2430 (Pubitemid 30399211)
    • (2000) Clinical Cancer Research , vol.6 , Issue.6 , pp. 2424-2430
    • Shirahama, T.1
  • 21
    • 16444380637 scopus 로고    scopus 로고
    • Transitional cell hyperplasia and carcinomas in urinary bladders of transgenic mice with keratin 5 promoter-driven cyclooxygenase-2 overexpression
    • DOI 10.1158/0008-5472.CAN-04-3567
    • Klein R. D., Van Pelt C. S., Sabichi A. L., Dela Cerda J., Fischer S. M., Frstenberger G., Mller-Decker K., Transitional cell hyperplasia and carcinomas in urinary bladders of transgenic mice with keratin 5 promoter-driven cyclooxygenase-2 overexpression Cancer Research 2005 65 5 1808 1813 (Pubitemid 40478608)
    • (2005) Cancer Research , vol.65 , Issue.5 , pp. 1808-1813
    • Klein, R.D.1    Van Pelt, C.S.2    Sabichi, A.L.3    Dela Cerda, J.4    Fischer, S.M.5    Furstenberger, G.6    Muller-Decker, K.7
  • 23
    • 0017228708 scopus 로고
    • Histological classification of urinary bladder cancers in rats induced by N butyl N (4 hydroxybutyl)nitrosamine
    • Fukushima S., Hirose M., Tsuda H., Histological classification of urinary bladder cancers in rats induced by N butyl N (4 hydroxybutyl)nitrosamine Gann, The Japanese Journal of Cancer Research 1976 67 1 81 90
    • (1976) Gann, the Japanese Journal of Cancer Research , vol.67 , Issue.1 , pp. 81-90
    • Fukushima, S.1    Hirose, M.2    Tsuda, H.3
  • 24
    • 15744398205 scopus 로고    scopus 로고
    • Preneoplastic lesions and conditions of the urinary bladder
    • DOI 10.1016/S1570-9124(03)00023-0
    • Montironi R., Mazzucchelli R., Preneoplastic lesions and conditions of the urinary bladder EAU Update Series 2003 1 2 53 63 (Pubitemid 40411073)
    • (2003) EAU Update Series , vol.1 , Issue.2 , pp. 53-63
    • Montironi, R.1    Mazzucchelli, R.2
  • 27
    • 34548392967 scopus 로고    scopus 로고
    • Optimizacin de un mtodo para la determinacin de la peroxidacin lipidica en suero humano
    • Estepa V., Rdenas S., Martn M. C., Optimizacin de un mtodo para la determinacin de la peroxidacin lipidica en suero humano Anales de la Real Academia de Farmacia 2001 67 3 1 17
    • (2001) Anales de la Real Academia de Farmacia , vol.67 , Issue.3 , pp. 1-17
    • Estepa, V.1    Rdenas, S.2    Martn, M.C.3
  • 28
    • 0030586361 scopus 로고    scopus 로고
    • The ferric reducing ability of plasma (FRAP) as a measure of antioxidant power: The FRAP assay
    • Benzie I. F. F., Strain J. J., The ferric reducing ability of plasma (FRAP) as a measure of antioxidant power: the FRAP assay Analytical Biochemistry 1996 239 1 70 76
    • (1996) Analytical Biochemistry , vol.239 , Issue.1 , pp. 70-76
    • Benzie, I.F.F.1    Strain, J.J.2
  • 29
    • 0034667354 scopus 로고    scopus 로고
    • Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats
    • Grubbs C. J., Lubet R. A., Koki A. T., Leahy K. M., Masferrer J. L., Steele V. E., Kelloff G. J., Hill D. L., Seibert K., Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats Cancer Research 2000 60 20 5599 5602
    • (2000) Cancer Research , vol.60 , Issue.20 , pp. 5599-5602
    • Grubbs, C.J.1    Lubet, R.A.2    Koki, A.T.3    Leahy, K.M.4    Masferrer, J.L.5    Steele, V.E.6    Kelloff, G.J.7    Hill, D.L.8    Seibert, K.9
  • 30
    • 34548125720 scopus 로고    scopus 로고
    • Anti-inflammatory and side effects of cyclooxygenase inhibitors
    • Sleyman H., Demircan B., Karagz Y., Anti-inflammatory and side effects of cyclooxygenase inhibitors Pharmacological Reports 2007 59 3 247 258 (Pubitemid 47299726)
    • (2007) Pharmacological Reports , vol.59 , Issue.3 , pp. 247-258
    • Suleyman, H.1    Demircan, B.2    Karagoz, Y.3
  • 31
    • 0034646688 scopus 로고    scopus 로고
    • The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2
    • DOI 10.1074/jbc.275.15.11397
    • Hsu A. L., Ching T. T., Wang D. S., Song X., Rangnekar V. M., Chen C. S., The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2 The Journal of Biological Chemistry 2000 275 15 11397 11403 (Pubitemid 30212792)
    • (2000) Journal of Biological Chemistry , vol.275 , Issue.15 , pp. 11397-11403
    • Hsu, A.-L.1    Ching, T.-T.2    Wang, D.-S.3    Song, X.4    Rangnekar, V.M.5    Chen, C.-S.6
  • 33
    • 0001501848 scopus 로고    scopus 로고
    • Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo
    • Liu X. H., Kirschenbaum A., Yao S., Lee R., Holland J. F., Levine A. C., Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo Journal of Urology 2000 164 3 820 825 (Pubitemid 30637640)
    • (2000) Journal of Urology , vol.164 , Issue.3 , pp. 820-825
    • Liu, X.H.1    Kirschenbaum, A.2    Yao, S.3    Lee, R.4    Holland, J.F.5    Levine, A.C.6
  • 34
    • 0041833663 scopus 로고    scopus 로고
    • Suppression of N-methyl-N-nitrosourea/testosterone-induced rat prostate cancer growth by celecoxib: Effects on cyclooxygenase-2, cell cycle regulation, and apoptosis mechanism(s)
    • Narayanan B. A., Condon M. S., Bosland M. C., Narayanan N. K., Reddy B. S., Suppression of N-methyl-N-nitrosourea/testosterone-induced rat prostate cancer growth by celecoxib: effects on cyclooxygenase-2, cell cycle regulation, and apoptosis mechanism(s) Clinical Cancer Research 2003 9 9 3503 3513 (Pubitemid 37082750)
    • (2003) Clinical Cancer Research , vol.9 , Issue.9 , pp. 3503-3513
    • Narayanan, B.A.1    Condon, M.S.2    Bosland, M.C.3    Narayanan, N.K.4    Reddy, B.S.5
  • 37
    • 33845212729 scopus 로고    scopus 로고
    • Interleukin-1 and cancer progression: The emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment
    • Lewis A. M., Varghese S., Xu H., Alexander H. R., Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment Journal of Translational Medicine 2006 4, article 48
    • (2006) Journal of Translational Medicine , vol.448
    • Lewis, A.M.1    Varghese, S.2    Xu, H.3    Alexander, H.R.4
  • 38
    • 77954551165 scopus 로고    scopus 로고
    • Why not treat human cancer with interleukin-1 blockade?
    • Dinarello C. A., Why not treat human cancer with interleukin-1 blockade? Cancer and Metastasis Reviews 2010 29 2 317 329
    • (2010) Cancer and Metastasis Reviews , vol.29 , Issue.2 , pp. 317-329
    • Dinarello, C.A.1
  • 39
    • 0034650771 scopus 로고    scopus 로고
    • Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis
    • Reddy B. S., Hirose Y., Lubet R., Steele V., Kelloff G., Paulson S., Seibert K., Rao C. V., Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis Cancer Research 2000 60 2 293 297 (Pubitemid 30070754)
    • (2000) Cancer Research , vol.60 , Issue.2 , pp. 293-297
    • Reddy, B.S.1    Hirose, Y.2    Lubet, R.3    Steele, V.4    Kelloff, G.5    Paulson, S.6    Seibert, K.7    Rao, C.V.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.